国家基本药物制度框架下药品电子监管政策研究  

Research on Drug Electronic Supervision Policy under the Framework of National Essential Drug System

作　　者：丁锦希[1] 李媛[1] 高强 

机构地区：[1]中国药科大学国际医药商学院,南京市211198 [2]南京市食品药品监督管理局,南京市211198

出　　处：《中国药房》2011年第48期4513-4516,共4页China Pharmacy

基　　金：江苏省食品药品监督管理局资助项目(20110016)

摘　　要：目的:为完善我国国家基本药物制度框架下药品电子监管政策提供参考。方法:系统介绍我国药品电子监管政策实施的目的、特点及推行步骤,通过对该政策实施绩效评价及借鉴国外成功经验,得出我国完善该政策的策略。结果与结论:药品电子监管是药品监管的必然趋势,当前的实施工作仍有不足之处。我国应借鉴国外成功经验,与本国实际相结合,进一步完善药品电子监管政策。To provide proposals to improve drug electronic supervision policy under the framework of National Essential Drug System. METHODS： This paper presented an in-depth analysis including the purpose, features and implementing steps toward drug electronic supervision policy. Suggestions were made to improve this policy through performance evaluation and introduction of drug electronic supervision policies in other countries. RESULTS ＆ CONCLUSIONS： Drug electronic supervision is a natural trend but still in its infancy. We should combine foreign experience with own conditions to promote this policy.

关 键 词：国家基本药物制度 药品电子监管 监管码 

分 类 号：R95[医药卫生—药学]